Syphilitic Uveitis on the Rise: A Rare but Vision-Threatening Epidemic
Please hit the ❤️ at the top or bottom of this email to help others discover All About Vision With Dr. Kondrot. Your subscription directly supports my ongoing humanitarian work—delivering free eye surgeries and care where it's needed most.
Story at a Glance:
Syphilitic uveitis, a rare but serious inflammatory eye disease, is increasing in incidence across the U.S.
Often linked to systemic syphilis infection, it poses a major risk of permanent vision loss if left undiagnosed or untreated.
A recent U.S. study found rising cases over the past decade, with many patients presenting late, leading to complications.
Routine syphilis testing for patients with unexplained uveitis is crucial for early intervention.
Prompt treatment with IV penicillin can prevent irreversible vision damage.
What Is Syphilitic Uveitis?
Syphilitic uveitis is an inflammation of the uveal tract caused by infection with Treponema pallidum, the bacterium responsible for syphilis. Though syphilis is typically recognized for its systemic effects, this sexually transmitted infection can also affect the eye, leading to vision-threatening complications.
Uveitis may be the first or only sign of syphilis in some individuals. The inflammation can affect any part of the eye, including the retina and optic nerve, and often presents with blurred vision, eye pain, floaters, and redness.
The New Data: A Growing Concern
A recent retrospective cohort study published in the American Journal of Ophthalmology (June 2025) analyzed syphilitic uveitis cases using the TriNetX database. Here’s what researchers found:
237 confirmed cases of syphilitic uveitis were identified among 161,317 patients with syphilis from 2013 to 2024.
The incidence was approximately 0.36 per 100,000, and prevalence was 0.27 per 100,000.
Affected individuals were predominantly male (75%) with a mean age of 52 years.
HIV coinfection was present in 32.5% of cases, further complicating diagnosis and prognosis.
Other sexually transmitted infections, such as gonorrhea and chlamydia, were also noted in a smaller percentage (~4.2%).
These findings suggest that syphilitic uveitis, though uncommon, may be underdiagnosed and increasing alongside the broader syphilis resurgence in the U.S.
The Vision Risk: How Bad Can It Get?
The study showed that:
79% of affected eyes involved posterior uveitis or panuveitis, both of which are associated with poor visual outcomes.
Low vision or blindness was common in patients presenting late or untreated.
Delayed diagnosis often results from misattributing symptoms to other forms of uveitis or ocular inflammation.
Vision loss from syphilitic uveitis is often preventable, but only if caught early.
Mainstream Medical Approach
Once diagnosed, the standard treatment for syphilitic uveitis is:
Intravenous penicillin G, administered for 10–14 days, as per CDC guidelines.
Corticosteroids may be added to control inflammation, but only after antibiotic therapy begins to avoid worsening infection.
Follow-up with infectious disease and ophthalmology is essential to monitor resolution and manage recurrence.
Holistic and Preventive Considerations
Although syphilitic uveitis requires medical therapy, holistic support can aid recovery and strengthen resilience:
Immune system support: Adequate sleep, stress management, and anti-inflammatory nutrition can help the body fight infections more effectively.
Ocular support nutrients: Zinc, vitamin C, and bioflavonoids may aid in tissue repair post-infection.
Sexual health education: Safer sex practices and routine STI testing reduce reinfection and protect long-term health.